Hypoxia Potentiates Notch Signaling in Breast Cancer Leading to Decreased E-cadherin Expression and Increased Cell Migration and Invasion

Overview

Journal Br J Cancer

Specialty Oncology

Date 2009 Dec 17

PMID 20010940

Citations 165

Authors

N Imanaka

J Chen

J D Griffin

Affiliations

Soon will be listed here.

Abstract

Background: Epithelial-to-mesenchymal transition (EMT) is associated with decreased adhesion and acquisition of metastatic potential of breast cancer cells. Epithelial-to-mesenchymal transition is mediated, in part, by two transcription repressors, Snail and Slug, that are known to be targets of the Notch signaling pathway, and JAGGED1-induced Notch activation increases EMT. However, the events that lead to increased Notch activity during EMT of breast cancer cells are unknown.

Methods: The accumulation of hypoxia inducible factors (HIFs) under hypoxia was detected by western blot analysis, and their effects on Notch signaling were measured by an in vitro Notch reporter assay. The expression of Notch target genes under hypoxia was tested by real-time PCR. The knockdown of HIF-1alpha was mediated by retroviral delivery of shRNA. The expression of Slug and Snail under hypoxia was measured by real-time PCR. Breast cancer cell migration and invasion under hypoxia were tested with cell migration and invasion kits.

Results: Hypoxia increased the expression of Notch target genes such as HES1 and HEY1 in breast cancer cells, as was expression of Notch receptors and ligands. The mechanism is likely to involve the accumulation of HIF-1alpha and HIF-2alpha in these cells by hypoxia, which synergised with the Notch co-activator MAML1 in potentiating Notch activity. Hypoxia inducible factor-1alpha was found to bind to HES1 promoter under hypoxia. Knockdown of HIF-1alpha with shRNA inhibited both HES1 and HEY1 expression under hypoxia. Hypoxia increased the expression of Slug and Snail, and decreased the expression of E-cadherin, hallmarks of EMT. Notch pathway inhibition abrogated the hypoxia-mediated increase in Slug and Snail expression, as well as decreased breast cancer cell migration and invasion.

Conclusion: Hypoxia-mediated Notch signaling may have an important role in the initiation of EMT and subsequent potential for breast cancer metastasis.

Citing Articles

Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring.

Zhang Z, Wang J, Wuethrich A, Trau M Natl Sci Rev. 2025; 12(3):nwae452.

PMID: 39926198 PMC: 11804803. DOI: 10.1093/nsr/nwae452.

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.

Canonical and noncanonical NOTCH signaling in the nongenetic resistance of cancer: distinct and concerted control.

Huang X, Chen W, Wang Y, Shytikov D, Wang Y, Zhu W Front Med. 2025; 19(1):23-52.

PMID: 39745621 DOI: 10.1007/s11684-024-1107-1.

Direct visualization of emergent metastatic features within an ex vivo model of the tumor microenvironment.

Anandi L, Garcia J, Ros M, Janska L, Liu J, Carmona-Fontaine C Life Sci Alliance. 2024; 8(1).

PMID: 39419548 PMC: 11487089. DOI: 10.26508/lsa.202403053.

Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment.

Capatina A, Malcolm J, Stenning J, Moore R, Bridge K, Brackenbury W Front Cell Dev Biol. 2024; 12:1421629.

PMID: 39282472 PMC: 11392762. DOI: 10.3389/fcell.2024.1421629.

References

Kiaris H, Politi K, Grimm L, Szabolcs M, Fisher P, Efstratiadis A . Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. Am J Pathol. 2004; 165(2):695-705. PMC: 1618582. DOI: 10.1016/S0002-9440(10)63333-0. View

Timmerman L, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares J, Diez J . Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004; 18(1):99-115. PMC: 314285. DOI: 10.1101/gad.276304. View

Weng A, Nam Y, Wolfe M, Pear W, Griffin J, Blacklow S . Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol Cell Biol. 2003; 23(2):655-64. PMC: 151540. DOI: 10.1128/MCB.23.2.655-664.2003. View

Chen Y, De Marco M, Graziani I, Gazdar A, Strack P, Miele L . Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res. 2007; 67(17):7954-9. DOI: 10.1158/0008-5472.CAN-07-1229. View

Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V . Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol. 2004; 167(2):215-21. PMC: 2172557. DOI: 10.1083/jcb.200406140. View

Park S, Gaur A, Lengyel E, Peter M . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008; 22(7):894-907. PMC: 2279201. DOI: 10.1101/gad.1640608. View

Gustafsson M, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J . Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell. 2005; 9(5):617-28. DOI: 10.1016/j.devcel.2005.09.010. View

Thiery J . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6):442-54. DOI: 10.1038/nrc822. View

Hu C, Dievart A, Lupien M, Calvo E, Tremblay G, Jolicoeur P . Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol. 2006; 168(3):973-90. PMC: 1606519. DOI: 10.2353/ajpath.2006.050416. View

10.

Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G . The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10(5):593-601. DOI: 10.1038/ncb1722. View

11.

Tavazoie S, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos P . Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008; 451(7175):147-52. PMC: 2782491. DOI: 10.1038/nature06487. View

12.

Wu L, Aster J, Blacklow S, Lake R, Artavanis-Tsakonas S, Griffin J . MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet. 2000; 26(4):484-9. DOI: 10.1038/82644. View

13.

Gallahan D, Callahan R . The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene. 1997; 14(16):1883-90. DOI: 10.1038/sj.onc.1201035. View

14.

Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready D . High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 2005; 65(18):8530-7. DOI: 10.1158/0008-5472.CAN-05-1069. View

15.

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

16.

Semenza G . HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002; 8(4 Suppl):S62-7. DOI: 10.1016/s1471-4914(02)02317-1. View

17.

Smith G, Gallahan D, Diella F, Jhappan C, Merlino G, Callahan R . Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth Differ. 1995; 6(5):563-77. View

18.

Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View

19.

Leong K, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I . Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med. 2007; 204(12):2935-48. PMC: 2118507. DOI: 10.1084/jem.20071082. View

20.

Mani S, Guo W, Liao M, Eaton E, Ayyanan A, Zhou A . The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133(4):704-15. PMC: 2728032. DOI: 10.1016/j.cell.2008.03.027. View